ZNF890P

Across TCGA pan-cancer cohorts, ZNF890P Mutation is linked to patient survival in 1 of 34 cancer types, making it a survival-associated ZNF890P data layer compared with 21 for mass-spec protein.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher ZNF890P Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated ZNF890P expression acts as an unfavorable survival marker.

LUAD are the cancer types where ZNF890P Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	OS	Median	II,III,IV	0.237	0.709	.039	6	view →

Pink = unfavorable, green = favorable. Showing the 1 strongest of 1 lineages.

ZNF890P–LUAD (OS)

Open the LUAD breakdown →